1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. COVID-19

RespiraSense for continuously monitoring respiratory rate

Medtech innovation briefing [MIB299] Published: 05 July 2022

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

RespiraSense is a CE marked IIb medical device.


  • Next